You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 10, 2024

Claims for Patent: 5,837,542

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 5,837,542

Title:	Intercellular adhesion molecule-1 (ICAM-1) ribozymes
Abstract:	Enzymatic RNA molecules which cleave ICAM-1 mRNA.
Inventor(s):	Grimm; Susan (Boulder, CO), Stinchcomb; Dan T. (Boulder, CO), McSwiggen; James (Boulder, CO), Sullivan; Sean (Boulder, CO), Draper; Kenneth G. (Boulder, CO)
Assignee:	Ribozyme Pharmaceuticals, Inc. (Boulder, CO)
Application Number:	08/292,620
Patent Claims:	1. An enzymatic RNA molecule which specifically cleaves intercellular adhesion molecule-1(ICAM-1) mRNA. 2. The enzymatic RNA molecule of claim 1, wherein said enzymatic RNA molecule is in a hammerhead motif. 3. The enzymatic RNA molecule of claim 1, wherein said enzymatic RNA molecule is in a hairpin, hepatitis delta virus, group 1 intron, or RNAseP RNA motif. 4. The enzymatic RNA molecule of any claims 1, 2 or 3, wherein said enzymatic RNA molecule comprises between 12 and 100 bases complementary to said mRNA. 5. The enzymatic RNA molecule of claim 4, wherein said enzymatic RNA molecule comprises between 14 and 24 bases complementary to said mRNA. 6. The enzymatic RNA molecule of claim 2 consisting essentially of any sequence defined as Seq. ID. Nos. 767-1526 and 2012-2390. 7. A mammalian cell including an enzymatic RNA molecule of any of claims 1, 2 or 3. 8. The mammalian cell of claim 7, wherein said mammalian cell is a human cell. 9. An expression vector including nucleic acid sequence encoding at least one enzymatic RNA molecule of any of claims 1, 2 or 3, in a manner which allows expression of that enzymatic RNA molecule. 10. A mammalian cell including the expression vector of claim 9. 11. The mammalian cell of claim 10, wherein said mammalian cell is a human cell. 12. The enzymatic RNA molecule of claim 2, wherein the binding arms of said enzymatic RNA molecule comprise sequences complementary to any of the sequences defined as Seq. ID. Nos. 7-776 and 1633-2011. 13. The enzymatic RNA molecule of claim 3, wherein the binding arms of said hairpin enzymatic RNA molecule comprise sequences complementary to any of the sequences defined as Seq. ID. Nos. 1544-1560, 1578-1594 and 1614-1632.

Details for Patent 5,837,542

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986	⤷ Try a Trial	2015-11-17
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132		⤷ Try a Trial	2015-11-17
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132		⤷ Try a Trial	2015-11-17
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.